13F-HR filed by JGP Global Gestao de Recursos Ltda.
JGP Global Gestao de Recursos Ltda. filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-04, with 15 holding rows worth $75,397,000.
- Accession
- 0001536562-17-000003
- Filer
- CIK 1536562
- Filed
- 2017-08-04
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 15 entries on the cover page, a total value of $75,397,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $75,397,000 with VALUE read as thousands by filing date, 13F file number 028-16384. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PowerShares QQQ Trust Unit Ser | 73935A104 | COM | 180,000 | $24,775,000 | thousands by filing date | put |
| SPY | 78462F103 | SHS | 100,000 | $24,180,000 | thousands by filing date | put |
| ISHARES TR | 464287234 | MSCI EMG MKT ETF | 350,000 | $14,487,000 | thousands by filing date | put |
| INCYTE CORP COM | 45337C102 | Stock | 23,300 | $2,934,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 19,264 | $1,750,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 11,333 | $1,472,000 | thousands by filing date | |
| UnitedHealth Group Inc | 91324P102 | COM | 7,850 | $1,456,000 | thousands by filing date | |
| ALEXION PHARMACEUTICALS INC | 015351109 | COM | 10,743 | $1,307,000 | thousands by filing date | |
| SEATTLE GENETICS INC | 812578102 | COM | 19,634 | $1,016,000 | thousands by filing date | |
| Eli Lilly and Company | 532457108 | COM | 6,426 | $529,000 | thousands by filing date | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 961 | $472,000 | thousands by filing date | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 2,697 | $348,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 2,294 | $321,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 5,890 | $271,000 | thousands by filing date | |
| ISHARES INC MSCI BRAZIL ETF | 464286400 | MSCI BRAZIL ETF | 2,300 | $79,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001536562-17-000003 | this filing | 2017-08-04 | acceptance time not in the bulk data set |